Authors


Rowena Yee Hoy, RN

Latest:

Clinical Systems Support Decision-making and Improve Safety

In my 15 years of oncology/hematology nursing experience, I�ve seen many errors and near-errors. No one is exempt from making mistakes, regardless of their experience level, and even a seemingly simple oversight can be dangerous for patients.


Alan Dove, PhD

Latest:

Healthcare IT Still Seeks a Security Blanket

August has traditionally been a sleepy month for government regulatory agencies, but this year, Washington's usual summer torpor was interrupted by a rush of new initiatives, as more than three-quarters of a trillion dollars from the American Recovery and Reinvestment Act surged into a mind- boggling range of projects.




Science, University of Kentucky College of Pharmacy

Latest:

Alogliptin: The newest agent to fight the diabetes pandemic

According to the American Diabetes Association (ADA), 23.6 million children and adults have diabetes (8% of the US population) and another 5.7 million cases remain undiagnosed. Epidemiologists predict that these statistics will double by 2030, further taxing the healthcare system. Medical expenditures are approximately 2.3 times higher for diabetic versus nondiabetic patients, and the annual cost of diabetes is estimated to be $116 billion.




The Doctors TV Show

Latest:

Child Vaccinations

As measles make a nationwide comeback, are parents who refuse to vaccinate their children contributing to the problem?




Howard Jack West, MDest, MD

Latest:

E-patients: The Genie is Out of the Bottle

Melissa received a metastatic lung cancer diagnosis just a few weeks after celebrating her 40th birthday. Within hours of hearing her diagnosis from her primary care physician, she started searching the Internet about her disease and what to expect in terms of treatments.





Joanne D. Schuijf, MSc

Latest:

Noninvasive coronary angiography with multislice computed tomography and myocardial perfusion imaging

A total of 114 patients with an intermediate pretest likelihood of coronary artery disease were evaluated with both multislice computed tomography (MSCT) and myocardial perfusion imaging (MPI). Results showed that in the majority of cases, a normal MSCT scan was associated with normal perfusion. However, only half of patients with significant stenoses showed abnormal perfusion. Accordingly, MPI and MSCT are intrinsically different techniques and appear to be complementary rather than overlapping as they provide information on atherosclerosis versus ischemia, respectively.


Frank J. Domino, Brandon Hecht, DO

Latest:

Massachusetts Healthcare Reform and Possible Insights into Affordable Care Act Future

Implementation of Massachusetts health care reform reduced all-cause mortality and mortality from causes amenable to health care








Florida Cardiovascular R

Latest:

Assessing risk through "inspired" care

This retrospective subanalysis of the Adenosine Sestamibi SPECT Post-Infarction Evaluation (INSPIRE) trial shows that early adenosine sestamibi stress testing is not only safe early after myocardial infarction (MI), but can also be very useful to identify patients at very low risk for events in the first year after discharge.



Einav Keet

Latest:

Insights on Rare MICPCH Syndrome Could Help with Autism, Epilepsy

Research into a rare neurological disorder may help researchers working on more common diseases including autism and epilepsy.



Alan H. Gradman, MD is Chief, Division of Cardiovascular Diseases

Latest:

Alcohol consumption and cardiovascular risk

We generally assume that having a good time must be bad for you,and no one would deny that irresponsible alcohol consumption takes a tremendous economic, social, and health-related toll on diverse populations all around the globe.


director, Division of Cardiology, George Washington University, Washington, DC.

Latest:

Drug-eluting stents and diseased saphenous vein grafts: Long-term risk in RRISC

Progressive disease in saphenous vein grafts remains a major short-term and long-term clinical challenge after surgical revascularization.


Pareena Bilkoo, MD, FACC

Latest:

Safety and Efficacy of Drug-Eluting Stents in Women

The safety and efficacy of drug-eluting stents are proven in the general population, but how do they perform in women?


Carl Convens, MD

Latest:

Late mortality with sirolimus-eluting stents in diseased saphenous vein grafts

In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts

© 2024 MJH Life Sciences

All rights reserved.